Validation of the CREB binding protein inhibitor, Pocenbrodib, as a novel therapy for advanced, hormone therapy-resistant prostate cancer
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
Pathos AI, Inc.
Start Date
October 24, 2023
End Date
April 23, 2026
Administered By
Medicine, Medical Oncology
Awarded By
Pathos AI, Inc.
Start Date
October 24, 2023
End Date
April 23, 2026